This study evaluated the possible impairments to endothelium-mediated vasodilation by structural and functional properties of the intestinal arterioles in adult (20-21-week-old) rats after 8-11 days or 7-8 weeks of streptozotocin-induced diabetes. Arteriolar intravascular pressures and luminal diameters were simultaneously measured during iontophoretic application of acetylcholine, bradykinin, and nitroprusside to the outer vessel wall, and passive diameter-pressure relations were obtained during maximal vasodilation. Microvascular pressures and circumference-passive wall tension relations were similar between all diabetic and normal rats and did not appear to significantly influence vasodilation. Both acute and chronic hyperglycemia were associated with near complete suppression of acetylcholine-induced vasodilation in large arterioles, and the threshold dose for vasodilation of intermediate arterioles was approximately 10-fold higher in diabetic rats. In both diabetic groups, dilatory responses to nitroprusside were normal, and in chronically diabetic rats, the relative vasodilation in response to various doses of bradykinin was equivalent to that found in normal rats. These observations indicate that a very specific deficit of acetylcholine-induced endotheliumderived relaxing factor action rapidly develops in intestinal arterioles of diabetic rats, but the arteriolar wall mechanical properties, cGMP-mediated muscle relaxation, and endothelial release of the bradykinin-stimulated relaxing factor are not compromised after 7-8 weeks of chronic hyperglycemia. (Circulation Research 1991;69:1259-1268 T here is increasing evidence that some aspect of endothelium-dependent vasodilation is impaired in both the arterial and arteriolar vessels of diabetic rats,1-4 rabbits,5 and humans.6 The typical observations indicate that vascular relaxation in response to acetylcholine, or to other agents that likely cause the release of a nitric oxide-type endothelium-derived relaxing factor,7 is suppressed in diabetes; however, agonists of smooth muscle cGMP activation cause relatively normal vasodilation.2,3,6 It is not currently known 1) whether abnormalities in endothelium-dependent vasodilation develop rapidly or slowly during the in vivo progression of diabetes, 2) whether they involve multiple or only specific types of endothelium-derived vasodilators, and 3) whether microvascular vasodilation is compromised by impaired structural distensibility of the arteriolar wall.
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This study evaluated the possible impairments to endothelium-mediated vasodilation by structural and functional properties of the intestinal arterioles in adult (20-21-week-old) rats after 8-11 days or 7-8 weeks of streptozotocin-induced diabetes. Arteriolar intravascular pressures and luminal diameters were simultaneously measured during iontophoretic application of acetylcholine, bradykinin, and nitroprusside to the outer vessel wall, and passive diameter-pressure relations were obtained during maximal vasodilation. Microvascular pressures and circumference-passive wall tension relations were similar between all diabetic and normal rats and did not appear to significantly influence vasodilation. Both acute and chronic hyperglycemia were associated with near complete suppression of acetylcholine-induced vasodilation in large arterioles, and the threshold dose for vasodilation of intermediate arterioles was approximately 10-fold higher in diabetic rats. In both diabetic groups, dilatory responses to nitroprusside were normal, and in chronically diabetic rats, the relative vasodilation in response to various doses of bradykinin was equivalent to that found in normal rats.
These observations indicate that a very specific deficit of acetylcholine-induced endotheliumderived relaxing factor action rapidly develops in intestinal arterioles of diabetic rats, but the arteriolar wall mechanical properties, cGMP-mediated muscle relaxation, and endothelial release of the bradykinin-stimulated relaxing factor are not compromised after 7-8 weeks of chronic hyperglycemia. (Circulation Research 1991;69:1259-1268)
T here is increasing evidence that some aspect of endothelium-dependent vasodilation is impaired in both the arterial and arteriolar vessels of diabetic rats,1-4 rabbits,5 and humans. 6 The typical observations indicate that vascular relaxation in response to acetylcholine, or to other agents that likely cause the release of a nitric oxide-type endothelium-derived relaxing factor,7 is suppressed in diabetes; however, agonists of smooth muscle cGMP activation cause relatively normal vasodilation.2,3,6 It is not currently known 1) whether abnormalities in endothelium-dependent vasodilation develop rapidly or slowly during the in vivo progression of diabetes, 2) whether they involve multiple or only specific types of endothelium-derived vasodilators, and 3) whether microvascular vasodilation is compromised by impaired structural distensibility of the arteriolar wall.
In evaluating the potential microvascular complications related to endothelium-dependent vasodila-tion, there are two major parameters that may influence the resultant magnitude of dilation. First, microvascular pressure is the force that expands the vessel luminal diameter as vascular smooth muscle relaxes; whether arteriolar pressures are normal in the diabetic microvasculature of any given organ is unknown. Second, structural changes in diabetic arterioles may alter vessel wall passive distensibility such that vasodilation is limited or augmented for a given reduction in vascular smooth muscle active force generation. Consequently, evaluation of results obtained from isolated arteries or whole-organ vascular responses in terms of events occurring in individual arterioles is difficult without direct measurements of microvascular mechanical and behavioral characteristics.
In this study, the impairments of endotheliumdependent vasodilation mediated by acetylcholine and bradykinin78 were studied in rats made both acutely and chronically diabetic with streptozotocin. Vascular responses to nitroprusside, a non-endothelium-dependent vasodilator,7 were also studied to evaluate the vascular smooth muscle capacity for vasodilation. Microiontophoretic application of the drugs to the outer wall of individual arterioles al-lowed assessment of a very localized vasodilation to be made independent of global changes in vascular hemodynamics. In addition, measurement of the active and passive diameter versus pressure relations allowed determination of both functional and mechanical contributions to disturbances in vasodilatory responses. The results obtained support the hypothesis that the diabetic state is associated with a rapid and chronic suppression of the action of endothelium-derived relaxing factor associated with acetylcholine, which neither complicates nor is complicated by active and passive mechanical properties of the precapillary vasculature.
Materials and Methods
Male Sprague-Dawley rats (Harlan Sprague Dawley, Inc., Indianapolis, Ind.) obtained at 20-21 weeks of age were given either 45 mg/kg streptozotocin or an equivalent amount the vehicle alone through a tail vein. At 7 days after injection, plasma glucose was elevated to at least 400 mg/dl in rats that received streptozotocin. These diabetic rats were randomly divided into two groups; the short-term group was studied 8-11 days after injection (DIAB-S rats), and the remainder, the long-term group, was studied during the seventh and eighth week after injection (DIAB-L rats). Normal (NORM) rats were those given vehicle alone. All rats were allowed free access to food and water until taken from the colony. For in vivo studies of the microvasculature, NORM rats were given 100 mg/kg sodium thiopental (100 mg/ml, 0.1 ml/100 g i.p., Abbott Laboratories, North Chicago, Ill.). We have found that diabetic rats require only 50-75 mg/kg sodium thiopental to reach a surgical level of anesthesia, as judged by loss of the eye closure reflex to touching the cornea and absence of a response to pinching the forelimb. As soon as mobility was lost after administration of the anesthetic agent (< 10 minutes), all rats were placed on a heated support (35-36°C) for the duration of the study. Esophageal temperatures were consistently 37-38°C throughout the experimental period.
The trachea was intubated with PE-190-240 tubing, and the left femoral artery was cannulated to measure arterial blood pressure. If the rat could not maintain a ventilation frequency of at least 60 breaths/min, a typical ventilation frequency for rats when conscious, the rat was placed on mechanical ventilation (70 breaths/min, 3 ml tidal volume) as a precaution until the surgery was completed. A 1.5-2-cm midline abdominal incision was used to expose the small intestine, and a loop of ileum was identified by finding the appendix. The intestinal microvasculature of the submucosal and muscular layers was prepared for observation with techniques previously described in detail.9 The exposed tissues were kept at 37-38°C and immersed in a flowing bath (5 ml/min) of physiological saline10 equilibrated with 5% 02 and 5% C02, with the balance N2. Motility of the small intestine was suppressed by addition of 10`7 g/ml isoproterenol (Sigma Chemical Co., St. Louis, Mo.) and 0.02 g/ml phenytoin (LyphoMed, Inc., Rosemont, Ill.) to the bathing solution. A prior study9 of normal adult rats has shown that these agents have minimal effects on resting intestinal blood flow and virtually eliminate bowel motion; these conditions are essential for prevention of vessel injury by micropipettes placed both in the lumen and on the outer wall of the arterioles. Tissue preparations were rejected if arterioles would not dilate at least 30% to topically applied adenosine (10`4 M), if petechial hemorrhages existed, if groups of capillaries were observed to have very low red blood cell flux, or if immobile intravascular clots or alternating areas of vasoconstriction and dilation occurred along arterioles. These criteria were used in the selection of 13 NORM rats, six DIAB-S rats, and 22 DIAB-L rats for data collection. Data collection during the experiment was discontinued if the arterial pressure was unstable, if the spontaneous ventilation frequency fell below 60 breaths/min after completion of surgery, if the rat required mechanical ventilation to maintain a constant arterial pressure, or if any of the microvascular rejection criteria listed above developed.
Acetylcholine, sodium nitroprusside, and bradykinin (Sigma) were applied to the wall of arterioles using a constant-current iontophoresis programmer (model 160, World Precision Instruments, Inc., New Haven, Conn.) and glass micropipettes sharpened to an outer tip diameter of 4-6 gm. Drug concentrations in the micropipette were 0.05 M for acetylcholine and 0.001 M for nitroprusside and bradykinin. All drugs were dissolved in distilled water. The tip of the iontophoretic micropipette was placed virtually in contact with the outer vessel wall and was adjusted as needed to maintain this relation during changes in vessel diameter. Inadvertent diffusion of the drug from the micropipette during control conditions was prevented by a 40-60-nA retaining current (polarity opposite to drug ion charge), although pipettes rarely caused even minimal vasodilation if no retaining current was used. Drug application persisted for a total of 2 minutes, and steady-state vascular responses were typically attained during the first minute of drug application. Measurements of luminal vessel diameter were made during the final 30 seconds of the 2-minute application period. After drug release was discontinued, a minimum of 2 minutes was allowed for the vessel to return to its steady-state resting diameter before the next 1-minute control period began.
Before placing the iontophoresis micropipette, the vessel was impaled at a downstream site (200-300 lm) with a micropipette sharpened to an outer tip diameter of 4-6 ,m. This pipette was used for measurement of internal distending pressure with a servo-null pressure measurement system (model 4A, Instrumentation for Physiology & Medicine, Inc., San Diego, Calif.) calibrated for measurements in a pressure range of 0-100 mm Hg. The localized vasodilation in response to drug release had virtually no effect on the intravascular pressure. This stability of pressure is expected with iontophoretic drug application, because the dilatory response was confined to within ±300-500 ,um of the site of drug release and the total upstream and downstream vascular resistances would not be significantly influenced. This is an important observation because, in some cases, we were forced to temporarily remove the pressure-measuring pipette during the response to a drug because of slight vessel or tissue movement that interfered with an accurate pressure measurement. In these cases, we assumed that microvascular pressure remained unchanged during the vascular response. To be sure that acetylcholine released onto the vessel wall caused vasodilation through an endothelium-derived relaxing factor mechanism, the blockade effects of N-monomethyl arginine (NMMA, Sigma) were tested on a separate group of NORM rats (n=3). Each arteriole was subjected to acetylcholine release from a micropipette (200 nA, 2 minutes) to be sure the vessel would dilate at least 30%. Thereafter, NMMA was applied by iontophoresis to the arteriolar wall at a current of 100 nA for 10 minutes from a micropipette with a 4-6-,m tip that contained a reservoir concentration of 10`4 M NMMA in distilled water. After NMMA release was stopped, the arteriole would not respond to acetylcholine in the area where NMMA had been released.
At the end of each experiment, the microvessels were rendered passive by an addition of i0`M sodium nitroprusside and 10-4 M adenosine to the bathing solution. The passive pressure-diameter relation was then determined by either partial occlusion of the inflow artery to the hemodynamically isolated bowel loop or reduction of the arterial pressure by systemic hemorrhage if the bowel loop was not fully hemodynamically isolated. Passive pressure-diameter relations were obtained for each vessel studied during drug application. Vessel images were obtained with an Olympus BHMJ microscope using a x 20 Nikon water immersion objective (n.a.=0.33) and x 10 oculars. The images were recorded using an RCA Model TC2011N camera and a Mitsubishi Model HS-329UR VHS video recorder and were displayed on a Panasonic TR-195MB video monitor. Vascular dimensions were measured with a video image shearing device'1 calibrated using a stage micrometer with 10and 100-,um divisions. The output of the device was recorded and averaged over a 15-30-second period using an IBM PC computer with a MetraByte Dash-8 (Metrabyte Corp., Stoughton, Mass.) analog-to-digital converter and software package. Recordings of systemic arterial pressure and microvascular pressure were made with a Gould Model 2400 recorder calibrated for each pressure-recording instrument.
One-way analyses of variance were used to detect differences between NORM and DIAB-S or DIAB-L rats. Two-way analyses of variance were used to identify group differences across various vessel types or across the range of drug delivery rates. Significant group differences were identified by least significant difference analysis at p 0.05. All statistical analyses were performed on an IBM-PC computer using the STAT-PACKETS Statistical Analysis Package (Wolonick Assoc., Minneapolis, Minn.) in conjunction with the LoTUS-1,2,3 data worksheet.
Results
The body weights, plasma glucose concentrations, and mean arterial blood pressures of the NORM, DIAB-S, and DIAB-L rats are listed in Table 1 . Both DIAB-S and DIAB-L rats had subnormal mean arterial pressures while anesthetized. However, both groups of diabetic rats maintained their mean arterial pressures nearly constant for -3 hours after completion of surgery, indicating reasonable cardiovascular and respiratory integrity. The loss of body weight began with the first week of hyperglycemia, and even DIAB-S rats had lost most of the fatty tissue in the mesentery by days 8-11 of the diabetic state.
A characteristic anomaly of both DIAB-S and DIAB-L rats was spontaneous and transient sticking, rolling, and release of white blood cells along the lining of arterioles. The entire three-part event seldom lasted more than 10 seconds and appeared to occur randomly in time and location along a given arteriole. This white blood cell anomaly did not occur in arterioles used for data collection in NORM rats. However, tissues of NORM rats damaged by inadvertent vascular occlusion, tissue drying, or excessive stretching did have evidence of white blood cell sticking in arterioles. Therefore, we were concerned that the white blood cell events in diabetic rats reflected microvascular damage either of natural origin or induced by some aspect of the surgical protocol. However, the white blood cell events in diabetic rats were evident even before micropipettes approached the vessel walls and occurred in the absence of any apparent tissue damage. As will be shown, other than specific suppression of the vascular response to acetylcholine, the diabetic microvasculature had nearly normal functional behavior. Therefore, the white blood cell events in diabetic rats are assumed to reflect a naturally occurring pathology. Figure 1 presents the microvascular pressure in the intestinal arterioles during resting and passive conditions, as well as the ratio of arteriolar to mean arterial pressure during both conditions for each group of rats studied. To maintain consistency of 1A
2A 3A and, in turn, the small-diameter (3A) arterioles were the first branches of each 2A arteriole. As shown in Figure 1 , during control (no drug) conditions, NORM and DIAB-L rats had equivalent pressures (upper left panel), but a higher fraction of the systemic arterial pressure was transmitted to the first and second generation arterioles in DIAB-L (lower left panel). In contrast, DIAB-S rats had lower control pressures in these arterioles, but a normal fraction of the mean systemic arterial pressure reached these vessels. In effect, during control conditions, the vasculature of the DIAB-L rats dissipated proportionately less of the systemic arterial pressure than that of NORM rats, allowing DLAB-L rats to have normal arteriolar pressures despite slight systemic hypotension. In contrast, the normal dissipation of systemic pressure in DIAB-S rats forced them to have hypotensive arteriolar pressures at their slightly hypotensive arterial pressure. During passive conditions, only pressures in the largest arterioles of DIAB-L rats were significantly elevated, and the fraction of systemic arterial pressure transmitted to the arterioles of both DIAB-L and DIAB-S rats was not statistically different (p>0.05) from that in NORM rats (Figure 1 , right panels). Therefore, passive intestinal hemodynamic properties of normal and diabetic rats were sufficiently similar to conclude that the abnormal micro-vascular pressures and altered fractional dissipation of systemic arterial pressure in the diabetic vasculature with arteriolar tone were primarily the result of active microvascular events. In this same context, the only significant abnormality of vessel diameter during control or passive conditions was enlargement of the largest (1A) arterioles of DIAB-L rats, as shown in Figure 2 . However, passive pressures in 1A arterioles of DIAB-L rats were also significantly higher than those in NORM rats, which could explain at least part of the observed enlargement of arteriolar diameter when vascular tone was present.
To determine if the circumference-passive tension properties of the arterioles were altered by shortor long-term diabetes, inner vessel wall tension was calculated (T=133.3xPxD/2,000,000, where P is pressure [mm Hg], D is diameter [gm], and T is tension [N/m]) and expressed as a function of vessel luminal circumference. The actual data of passive wall tension versus inner vessel circumference for each type of vessel studied in each rat model are shown in Figure 3 (1A arterioles in the left panel and 2A arterioles in the right panel). Coefficients for the line of best fit (average r=0.934) were determined for these data using linear regression analysis of the logl0(tension) versus circumference relation for each vessel over the range of minimum and maximum circumferences actually observed as the intravascular pressures were lowered and raised (see "Materials and Methods"). Note that, for a given vessel type, the curves are nearly parallel to each other, which would tend to indicate comparable mechanical properties for vessels of different diameter within a given branch order. Comparisons of the aver- Based on the anatomic sites chosenfor measurement (see 'Results"), only the JA arterioles ofDIAB-L rats had enlarged diameters in both resting and passive states. Diameter measurements were obtained from all rats listed in Table 1 .
age slope and intercept of the regression relations ( Table 2) indicate no significant differences between passive mechanical properties of normal vessels and those of DIAB-L or DIAB-S rats. Therefore, there is no evidence of passive structural impediments to vasodilation in the intestinal arterioles after 7-8 weeks of severe hyperglycemia. During control conditions and drug application, total wall tension was calculated as previously described, using simultaneous intravascular pressure and diameter measurements. Active wall tension was calculated as the difference between total wall tension and the passive wall tension determined for the prevailing circumference using the circumference-passive tension relation. The ratio of active to total wall tension during control conditions (Figure 4 diameter. The only indication of an abnormality in active tension generation was a reduced active to total tension ratio in the 2A arterioles after short-term hyperglycemia (DLAB-S rats). The location of the resting circumference and active tension along the circumference-active tension relation was evaluated to determine if arterioles of diabetic rats are on the rising or falling portion of curve. The circumference-active tension relation (AT) was derived by calculating the total wall tension (T) at the prevailing arteriolar pressure for each circumference of interest and then subtracting the passive tension (PT) associated with the corresponding circumference (AT=T-PT). This technique has been previously published in detail.'2 The point along this curve that corresponded to the vessel circumference and active tension generation during control conditions was known from the original measure- arteriolar type and rat group studied. The relations reflect the actual range of circumferences measured, and the curves are based on the least-squares fit as described in 'Results. " Circumference-passive tension relations were not different between comparably sized arterioles of normal (NORM), short-tern diabetic (DL4B-S), and long-term diabetic (DL4B-L) rats; the average slope and intercept and their appropriate standard errors were determined for the log1o(tension) vs. circumference relations in each group of rats studied. These coefficients are presented in Table 2 . ments and was compared to the peak of the relation for each vessel. The average data for each group of rats are presented in Figure 5 . During control conditions, the NORM 1A and 2A arterioles of the intestine maintained an active tension and circumference very near the peak of the circumference-active tension relation ( Figure 5 ). This observation of nearpeak active tension generation in normal adult Sprague-Dawley rats was identical to that previously obtained for intestinal arterioles of adult Wistar-Kyoto rats. 12 Near-peak resting active tension generation was also found in the 1A and 2A arterioles of both the DIAB-S and DIAB-L rats. However, 1A arterioles of DIAB-L rats developed substantially more resting active tension than equivalent branch order arterioles of NORM rats. (NORM), short-term diabetic (DLAB-S), and long-term diabetic (DIAB-L) rats. In general, vessels of all diabetic rats maintained a normal dependence ofresting diameter on active tension generation, with the exception of reduced active/total tension in 2A arterioles of DIAB-S rats. Data are based on measurements in three to seven vessels of each type in each group of rats.
To determine if possible differences in morphology of the vascular smooth muscle layer of the vascular wall or alterations of control arteriolar diameters might influence the vascular regulation and force development in diabetic arterioles, muscle layer wall stress was mathematically modeled using histological and mechanical measurements. Drs. Bret Connors and Andrew Evans (unpublished observations, Department of Anatomy, Indiana University School of Medicine) provided us with the average thickness of the endothelium-basement membrane layer and average cross-sectional area of the muscle layer of 1A and 2A arterioles of comparably aged normal and streptozotocin-treated rats (6-8 weeks hyperglycemic). Their data indicate that the total cross-sectional area of vascular smooth muscle is comparable between normal and diabetic rats for both 1A and 2A intestinal arterioles. From their data and our in vivo determinations of luminal vessel diameter, we were able to estimate the muscle layer thickness of each vessel branch order for any given vessel diameter. Active tension generation at the corresponding vessel diameter was divided by the calculated muscle layer thickness to estimate active wall stress within the vascular smooth muscle layer. These mathematical predictions indicate that 2A arterioles of long-term diabetic animals generate muscle wall stresses similar in magnitude to those of normal animals. This result is not unexpected since the normal and diabetic vessels have equivalent resting active tensions and diameters (Figure 2 ), arteriolar pressures (Figure 1) , and muscle morphology. During control conditions, the active muscle wall stress in 1A arterioles of DIAB-L rats was estimated to be -2.05 times greater than that in NORM rats, because of both an increased luminal vessel diameter and the consequently smaller muscle layer thickness. As a frame of reference, control active tension generation was 1.65 times higher in 1A arterioles of DIAB-L rats than those of NORM rats (Figure 5 ), because of larger 1A diameters but normal arteriolar pressures (Figures 1  and 2) . Figure 6 presents the relative changes in arteriolar diameter and active tension generation as progressively higher iontophoretic currents were used to release acetylcholine onto the vessel wall. The average responses of 1A arterioles in both DIAB-S and DIAB-L rats indicate an overall suppression of the dilatory response to acetylcholine, even though these vessels dilated normally (20-30%) in response to iontophoretically applied nitroprusside (Figure 7 ) and vascular diameters increased by >30% during topical application of a nitroprusside-adenosine mixture (Figure 2) . The threshold of the dose-dilation response (>110% of control vessel diameter) of 2A arterioles in DIAB-L and DIAB-S rats was at a current -10 times that for normal vessels (100 versus 10 nA, respectively). However, the 2A arterioles of DIAB-S and DIAB-L rats were capable of acetylcholine-induced dilation equivalent that in NORM rats at an iontophoretic current of 500 nA; in addition, Although a unique situation exists for each vessel type in each rat model, all vessels maintained a resting circumference/active tension intercept near the peak possible active tension for the prevailing resting microvascular pressure (see Figure 1 ). Data are based on measurements in three to seven vessels of each type in each group of rats. The active/peak tension ratio for each group is as follows: for JA arterioles, NORM=85+±8 4 (n=3), DIAB-S=83±16.8 (n=7), and DL4B-L=91+4.4 (n=3);for2A arterioles, NORM=82+6.3 (n=4), DIAB-S=74±8.3 (n=4), and DI4B-L=85±13.1 (n=3). the vasodilation in response to 500 nA acetylcholine application in both NORM and diabetic rats approached that observed during 500 nA iontophoretic application of sodium nitroprusside (Figure 7) . The change in active vessel wall tension during acetylcholine application was compared in all three groups of rats. To facilate comparison, the data are expressed as percent of control active tension at a given dosage because the absolute resting wall tensions between rat types are different ( Figure 5 rats were incapable of responding to ACH, and the dose-response relation for 24 arterioles was shifted by an order of magnitude to a higher threshold dose. For the vessels that did dilate, active tension does not appreciably decrease unless near maximum vasodilation was elicited. Number of vessels studied in NORM, DIABS-S, and DIAB-L, respectively, are as follows: for 1A, 9, 14 , and 5; for 24, 11, 22, and 3. Figure 6 , their responses to NP were essentially normal.
application because of their very limited dilation ( Figure 6 ). However, when vasodilation did occur, as in the 2A arterioles shown in the right panel of Figure 6 , active tension generation did not necessarily decrease if the magnitude of the vasodilation was less than maximal. The typical response of both NORM and diabetic arterioles that did dilate was a lengthening of the vessel circumference with a minor change in active tension generation. This is not a unique property of acetylcholine-induced endothelium-dependent vasodilation, because a prior study of adenosine-induced vasodilation of normal intestinal arterioles yielded similar results.12 The altered dilatory responses to acetylcholine in arterioles from diabetic rats could be related to a suppressed release of endothelium-derived relaxing factor, to an inappropriate response by the vascular smooth muscle cell to the relaxing factor, or to some combination of both. To identify the specific location of the abnormality, nitroprusside was iontophoretically applied to the outer vessel wall to directly influence regulation of the cytosolic GMP of vascular smooth muscle in a manner believed to be similar to the actions of nitric oxide,7 the form of endotheliumderived relaxing factor currently thought to be released by acetylcholine. As shown in Figure 7 , the nitroprusside dose-response curves of arterioles from NORM, DIAB-S, and DIAB-L rats are virtually equivalent, with one minor exception. This exception of unknown cause is that very low current dosages of nitroprusside from a reservoir concentration of 0.001 M caused a slight constriction of NORM arterioles, whereas arterioles of DIAB-S and DIAB-L rats either had no response or a minimal dilatory response. However, the overall data set is consistent with the proposal that vascular smooth muscle cells of diabetic rats retain the ability to respond normally to cGMP activators; therefore, the altered response to acetylcholine reflects a deficit in endothelial cell function.
In six NORM and six DIAB-L rats, the responses of the same arteriole to iontophoretically applied acetylcholine and bradykinin were tested. The vascular responses to these drugs were compared because both require endothelial cell mediation to elicit vasodilation, but they act through release of different relaxing factors.7,8 The responses to bradykinin for 1A and 2A arterioles were averaged together in both normal and diabetic rats because there were no vessel order-dependent differences as judged by analysis of variance. The vascular responses to bradykinin application are shown in Figure 8 . Dilation to bradykinin was evident in DIAB-L rats, and the magnitude was equal to or exceeded that in NORM rats at equivalent iontophoretic application currents. However, as previously described in Figure 6 , the response to acetylcholine was virtually absent in IA arterioles of diabetic rats, and the threshold dose was shifted to a much higher iontophoretic current in diabetic 2A vessels. All vessels tested responded with dilation in response to bradykinin application, including those in diabetic rats with virtually no dilatory response to acetylcholine. However, the response to bradykinin was more variable in diabetic rats than normal rats for unknown reasons.
Discussion
Korthuis et a113 have reported that resting intestinal vascular resistance in adult rats after 4 weeks of streptozotocin-induced diabetes is decreased by 37%. Their study indicates that most of the decreased resistance could be attributed to functional abnormalities related to plasma hyperosmolarity and increased glucagon. Our measurements of both rest- ing arteriolar diameters and microvascular pressures in chronically diabetic rats indicate vasodilation of the largest arterioles and reduced pressure dissipation by the small arteries preceding the microcirculation and by the large arterioles within the microcirculation (Figures 1 and 2) , reflecting a reduced arterial vascular resistance. A prior study by Unthank and Bohlen14 has shown that no appreciable change in numbers of intestinal arterioles occurs after prolonged streptozotocin-induced diabetes. Therefore, the arterial portions of the intestinal vasculature and the largest arterioles of the bowel wall appear to be the primary sites of reduced intestinal vascular resistance during chronic, severe hyperglycemia. We found very little evidence to support the hypothesis of a structural component to the decreased resistance of these vascular regions because, after vascular tone was abolished, the fraction of arterial pressure transmitted to these vessels was normalized (Figure 1 ). In addition, the passive mechanical properties of 1A and 2A arterioles, as evaluated by circumferencepassive tension relations, were equivalent between NORM and diabetic rats (Figure 3 ). The absence of structural impediment or augmentation of vasodilation and presence of normal arteriolar pressures in the chronically diabetic rats are important in that any deficits of actively mediated vasodilation are primarily functional in origin. Our overall results support previous studies in diabetic animals and humans2-6,15 that have found decreased endothelium-dependent vasodilation in response to acetylcholine, yet normal vasodilation in response to a direct cGMP agonist, such as sodium nitroprusside used in the current study (Figures 6 and 7) . However, the current study also demonstrates that the endo-thelium response to acetylcholine is significantly suppressed after as little as 1 week of sustained hyperglycemia and that the response does not significantly improve or further degenerate after 7-8 weeks of hyperglycemia ( Figure 6 ). Therefore, some as-yetunknown facet of diabetes causes a very rapid and sustained suppression of this specific response, which is likely elicited by the release of nitric oxide from endothelium cells in response to acetylcholine activation.7 It is very unlikely that this diabetic endothelial abnormality has a hemodynamic origin related to inadequate perfusion or tissue oxygenation. Korthuis et a113 have shown that intestinal blood flow is elevated in rats with streptozotocin-induced diabetes, and Bohlen'0 has reported that tissue oxygen tension is equivalent in normal and chronically hyperglycemic rats with streptozotocin-induced diabetes.
The dilatory responses of the arterioles of diabetic rats to various dosages of nitroprusside, which activates the cytosolic form of cGMP,7 were very similar to those of NORM arterioles (Figure 7) . Therefore, the loss or suppression of responses to acetylcholine was primarily of endothelial origin. However, this by no means indicates that all functions of diabetic endothelial cells are abnormal. The endotheliumdependent dilatory response to bradykinin was completely intact in DIAB-L rats (Figure 8) , even though the acetylcholine-induced endothelium-dependent dilation was significantly impaired (Figures 6 and 8) . The vasodilatory action of bradykinin seems to involve formation of an oxygen radical that is distinctly different from nitric oxide and its closely related compounds.8 As additional evidence of at least partial preservation of endothelial and vessel wall function in severe diabetes, Unthank and Bohlen14 have shown that the intestinal microvasculature of diabetic rats is capable of normal growth during juvenile life and forms additional functional capillaries to maintain approximately normal intercapillary distances as the muscle layers undergo the typical intestinal hypertrophy of untreated insulin-dependent diabetes.
For these structural microvascular responses to occur, it is reasonable to assume that the endothelial cells must cooperate in the vessel growth process, particularly when new functional capillaries are formed.
Placing the deficit of one form of endotheliumdependent vasodilation during diabetes into perspective is difficult because virtually all of the vascular parameters measured in the diabetic rats were within the normal range. Although much has been proposed regarding the potential physiological functions of the nitric oxide compound, the long-term macrovascular or microvascular consequences resulting from suppression of its release have not been determined. In this context, the results obtained in the current study are interpreted to predict that the very specific abnormality of reduced release of the nitric oxidetype endothelium-derived relaxing factor has very little to do with the passive mechanical properties or the cGMP-mediated relaxation of the intestinal arte-rioles (Figures 3 and 7 ). However, one concern is that nitric oxide has been implicated in the inhibition of activation and adhesion of blood elements to the endothelium.716 In the current study, we noted in virtually every diabetic rat that white blood cells or very small "clear" clots transiently rolled along the lining of the arterioles. A similar situation, including spontaneous formation of intravascular clots, has been observed in skeletal muscle arterioles in prior in vivo microcirculatory studies on mice made diabetic as young adults.17 Such events are so rare in normal rodents that their occurrence indicates an acutely damaged tissue preparation, yet we found no evidence of acute microvascular trauma in the diabetic rats. Exactly how detrimental sporadic white blood cell or platelet interactions with arteriolar endothelial cells are to the microvasculature is questionable, but such occurrences should not be dismissed as trivial until more information is available.
